While investing in the future is the best long term strategy, buying lower quality stocks like Ambertech (ASX:AMO) and Yellow Brick Road (ASX:YBR) can still pay off.

The EML Payments (ASX:EML) share price is down around 34% on regulatory concerns that could undermine its reputation globally.

Investing is a long term game but shorting is not investing, and it is not long term!

With a P/E of around 8, this business is either unsustainable, or cheap; welcome to the world of the “value investor”…

With the share price now well below my purchase price it’s time to check in on what went wrong…

One of the easiest ways to get started as an ethical investor is to buy one of these ASX listed ethical ETFs.

These 2 under the radar micro-caps may be high risk, high reward, but they seem to be heading in the right direction.

Corum Group improved its cash burn during the quarter, but shareholders might have to wait a while for organic top line growth to resurface.

AVA Risk, Eroad and Audinate are all ASX small caps worth following, given their long term business growth.

My original Whispir (ASX: WSP) thesis has played out nicely but I no longer find the risk vs reward attractive.

We bought a beach house, so I’m cashing out some of my stocks.

Less than a year after we published “The Case For Alcidion” the stock is up 160%, so it’s time to revisit the thesis.

Dusk Group (ASX:DSK) isn’t the kind of software compounder I love most, but it is arguably a short term trade set up…

Adir Shiffman, executive chairman of Catapult International, has been sharing some interesting tweets about covid-19.

8Common (ASX: 8CO) and Mach7 Technologies (ASX: M7T) are two small Aussie software stocks with strong share price momentum.

Yesterday, I appeared on Ausbiz’s the Call to discuss a range of stocks with Adam Dawes and Nadine Blaney. Of particular interest may be our discussions of Ansarada (ASX: AND) and Eroad (ASX:ERD). The discussion of Eroad starts at 2 minutes and 40 seconds, in the video below, while the discussion of Ansarada starts at … Continued

The Neuronode (device) and Trilogy (software), are used to help people with motor neuron disease, multiple sclerosis, cerebral palsy, and similar conditions

This makes the claimed “remaining short to medium term enterprise pipeline of some 15-20,000 connected vehicles,” in Australia seem more achievable than ever.

SkyFii’s acquisition of CrowdVision will add annualised recurring revenues (ARR) of around $2.3m (AUD) bringing pro forma SkyFii ARR to $13.3m.

By cultivating a strong relationship with retail shareholders, Rightcrowd (ASX:RCW) could increase its capital raising options…